Global Markets Direct: Next Generation Sequencing (Ngs) Market By Technology

July 26, 2012 - PRLog -- Global Markets Direct: Next Generation Sequencing (Ngs) Market By Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications & Tools - Global Trends & Forecasts (2011 – 2016)

For more information please click the link below
http://www.globalmarketsdirect.com/Report.aspx?ID=Next%C2%A0Generation%C2%A0Sequencing-Ngs%C2%A0Market-By%C2%A0Technology%C2%A0Pyrosequencing%C2%A0%C2%A0Others-Competitors%C2%A0Illumina%C2%A0454%C2%A0Roche%C2%A0Life-Science%C2%A0Technologies%C2%A0Applications%C2%A0%C2%A0Tools--%C2%A0Global%C2%A0Trends%C2%A0%C2%A0Forecasts-2011%C2%A0-%C2%A02016&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare&CompanyID=prlog

Global Markets Direct has added a new report Next Generation Sequencing (Ngs) Market By Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications & Tools - Global Trends & Forecasts (2011 – 2016)to its market research offerings. Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools - Global Trends and Forecasts (2011-2016)
Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.

The major drivers for the growth of NGS market is advancement of technologies and decrease of price of the tests being conducted with increased promotion made by the research institutions for use of DNA sequencers or NGS technology. Similarly, this technology has overridden the microarray technology and currently many institutes prefer the NGS platforms over microarrays. Similarly, greater interest has been observed in the field of cancer and personalized medicines. As the prices are expected to decrease further in the coming years, NGS testing may be considered for reimbursement under the health insurance policies. Lack of reimbursements, pricing cuts lack of skilled labor is hampering the growth of the NGS market globally. Similarly storage of the data is a major concern for the sequencing industry at present.

Scope of the Report:

The report evaluates the NGS market globally with respect to revenue, growth, and industry focus in the following markets:
Global NGS market, by technology
   Pyrosequencing
   Sequencing by synthesis
   Sequencing by hybridization
   Single molecule real time sequencing

For Table of Contents and Sample Pages please click the link below
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?...

or

Visit our Report Store

http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782